Inovio Pharmaceuticals Aims To Have More Than 1 Million COVID19 Vaccines By End Of Year

San Diego's Inovio working to develop universal COVID-19 vaccineПодробнее

INOVIO begins phase 1 clinical trial for vaccineПодробнее

WHO Says 70 Vaccines in the Works, With Three Leading CandidatesПодробнее

Covid-19 Vaccine Could Be Available This Year, Inovio Co-Founder SaysПодробнее

Inovio Pharmaceuticals Aims To Have More Than 1 Million COVID19 Vaccines By End Of YearПодробнее

Inovio Pharmaceuticals CEO on virus vaccine human trials, completing volunteer enrollment in AprilПодробнее

Advantages of DNA Vaccines in Response to the COVID-19 OutbreakПодробнее

Inovio PharmaceuticalsПодробнее

INOVIO Pharmaceuticals initiates phase one human clinical trial for COVID-19 vaccineПодробнее

Inovio’s COVID19 VaccineПодробнее

San Diego company says it's on the road to developing a coronavirus vaccineПодробнее

Inovio - Infectious DiseasesПодробнее

Coronavirus: Inovio Pharmaceuticals CEO talks conducting vaccine trialsПодробнее

DNA Medicines: From COVID-19 to CancerПодробнее

INOVIO DNA Medicine MOAПодробнее

Local Lab Making Progress On Coronavirus VaccineПодробнее

Inovio's COVID-19 Vaccine Set To Go Through Critical Stage Three TrialПодробнее

Kate Broderick: INO-4800 – A DNA based vaccine against COVID-19Подробнее

How a Covid-19 Vaccine Human Trial WorksПодробнее

INOVIO DNA Immunotherapy and GBMПодробнее